https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00372-2/fulltext
0
0
9/26/22 at 11:00pm
Organization
The Lancet
Authors
Years of research exploring mRNA vaccines for cancer treatment in preclinical and
clinical trials have set the stage for the rapid development of mRNA vaccines during
the COVID-19 pandemic. Therapeutic cancer vaccines based on mRNA are well tolerated,
and the…
Create an account
or login to join the discussion